Ginsenoside Rg1 protects primary cultured rat hippocampal neurons from cell apoptosis induced by β-amyloid protein

Pharmaceutical Biology

Volumn 49, Issue 5, 2011, Pages 501-507

  Gong, Li ^a   Li, Shu Ling ^a   Li, Hui ^b   Zhang, Lei ^c  

^a SHANDONG UNIVERSITY   (China)

^b DEZHOU UNIVERSITY   (China)

^c GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

amyloid protein; Alzheimer's disease; ginsenoside Rg1; neuroprotection

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; CASPASE 3; GINSENOSIDE RG 1; LACTATE DEHYDROGENASE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG RESPONSE; ENZYME ACTIVITY; HIPPOCAMPUS; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; RAT; UPREGULATION;

AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; CYTOPROTECTION; GINSENOSIDES; HIPPOCAMPUS; NEURONS; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR;

PANAX GINSENG; RATTUS;

EID: 79955053353     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2010.521514     Document Type: Article

References (35)

1. Adams JM, Cory S. (1998). The Bcl-2 protein family: arbiters of cell survival. Science 281:1322-1326. (Pubitemid 28406819)
2. Ashe PC, Berry MD. (2003). Apoptotic signaling cascades. Prog Neuropsychopharmacol Biol Psychiatry 27:199-214. (Pubitemid 36351488)
3. Bastianetto S, Ramassamy C, Poirier J, Quirion R. (1999). Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res 66:35-41. (Pubitemid 29148331)
4. Behl C. (2002). Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 3:433-442. (Pubitemid 135711799)
5. Beresford SA, Weiss NS, Voigt LF, McKnight B. (1997). Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet 349:458-461. (Pubitemid 27077825)
6. Chan RY, Chen WF, Dong A, Guo D, Wong MS. (2002). Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng. J Clin Endocrinol Metab 87:3691-3695. (Pubitemid 34879514)
7. Chao DT, Korsmeyer SJ. (1998). BCL-2 family: regulators of cell death. Annu Rev Immunol 16:395-419. (Pubitemid 28183370)
8. Chen XC, Zhu YG, Zhu LA, Huang C, Chen Y, Chen LM, Fang F, Zhou YC, Zhao CH. (2003). Ginsenoside Rg1 attenuates dopamineinduced apoptosis in PC12 cells by suppressing oxidative stress. Eur J Pharmacol 473:1-7. (Pubitemid 36851622)
9. Collaborative Group on Hormonal Factors in Breast Cancer. (1997). Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 350:1047-1059.
10. Desagher S, Martinou JC. (2000). Mitochondria as the central control point of apoptosis. Trends Cell Biol 10:369-377. (Pubitemid 30612469)
11. Gao QG, Chen WF, Xie JX, Wong MS. (2009). Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways. J Neurochem 109:1338-1347.
12. Goodenough S, Schäfer M, Behl C. (2003). Estrogen-induced cell signalling in a cellular model of Alzheimer's disease. J Steroid Biochem Mol Biol 84:301-305. (Pubitemid 36514845)
13. Green PS, Gridley KE, Simpkins JW. (1996). Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci Lett 218:165-168. (Pubitemid 26388841)
14. Gross A, McDonnell JM, Korsmeyer SJ. (1999). BCL-2 family members and the mitochondria in apoptosis. Genes Dev 13:1899-1911.
15. Huang KC, Williams WM. (1999). The Pharmacology of Chinese Herbs. Boca Raton: CRC Press.
16. Irie K, Murakami K, Masuda Y, Morimoto A, Ohigashi H, Ohashi R, Takegoshi K, Nagao M, Shimizu T, Shirasawa T. (2005). Structure of beta-amyloid fibrils and its relevance to their neurotoxicity: implications for the pathogenesis of Alzheimer's disease. J Biosci Bioeng 99:437-447. (Pubitemid 40874521)
17. Jellinger KA. (2000). Cell death mechanisms in Parkinson's disease. J Neural Transm 107:1-29. (Pubitemid 30077039)
18. Kawasumi M, Hashimoto Y, Chiba T, Kanekura K, Yamagishi Y, Ishizaka M, Tajima H, Niikura T, Nishimoto I. (2002). Molecular mechanisms for neuronal cell death by Alzheimer's amyloid precursor protein-relevant insults. Neurosignals 11:236-250. (Pubitemid 37494391)
19. Kim H, Park BS, Lee KG, Choi CY, Jang SS, Kim YH, Lee SE. (2005). Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. J Agric Food Chem 53: 8537-8541. (Pubitemid 41608910)
20. Kim TW, Pettingell WH, Jung YK, Kovacs DM, Tanzi RE. (1997). Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science 277:373-376. (Pubitemid 27450710)
21. Leung KW, Yung KK, Mak NK, Chan YS, Fan TP, Wong RN. (2007). Neuroprotective effects of ginsenoside-Rg1 in primary nigral neurons against rotenone toxicity. Neuropharmacology 52:827-835. (Pubitemid 46227475)
22. Mackey R, Eden J. (1998). Phytoestrogens and the menopause. Climacteric 1:302-308. (Pubitemid 128691313)
23. Miller DK. (1997). The role of the caspase family of cysteine proteases in apoptosis. Semin Immunol 9:35-49. (Pubitemid 27166010)
24. Nuydens R, Dispersyn G, Van Den Keiboom G, de Jong M, Connors R, Ramaekers F, Borgers M, Geerts H. (2000). Bcl-2 protects against apoptosis-related microtubule alterations in neuronal cells. Apoptosis 5:43-51. (Pubitemid 30146389)
25. Oltvai ZN, Milliman CL, Korsmeyer SJ. (1993). Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619. (Pubitemid 23259742)
26. Pereira C, Ferreiro E, Cardoso SM, de Oliveira CR. (2004). Cell degeneration induced by amyloid-beta peptides: implications for Alzheimer's disease. J Mol Neurosci 23:97-104. (Pubitemid 41359192)
27. Pike CJ, Walencewicz-Wasserman AJ, Kosmoski J, Cribbs DH, Glabe CG, Cotman CW. (1995). Structure-activity analyses of betaamyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity. J Neurochem 64:253-265.
28. Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang HG. (1994). Interactions among members of the Bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 91:9238-9242. (Pubitemid 24297889)
29. Takai N, Nakanishi H, Tanabe K, Nishioku T, Sugiyama T, Fujiwara M, Yamamoto K. (1998). Involvement of caspase-like proteinases in apoptosis of neuronal PC12 cells and primary cultured microglia induced by 6-hydroxydopamine. J Neurosci Res 54: 214-222. (Pubitemid 28469062)
30. Tanzi RE, Bertram L. (2005). Twenty years of the Alzheimer's disease amyloid hypothesis: A genetic perspective. Cell 120:545-555. (Pubitemid 40269768)
31. Thornberry NA, Lazebnik Y. (1998). Caspases: Enemies within. Science 281:1312-1316. (Pubitemid 28406817)
32. Xie C, Markesbery WR, Lovell MA. (2000). Survival of hippocampal and cortical neurons in a mixture of MEM+ and B27-supplemented neurobasal medium. Free Radic Biol Med 28:665-672. (Pubitemid 30171279)
33. Xu H, Gouras GK, Greenfield JP, Vincent B, Naslund J, Mazzarelli L, Fried G, Jovanovic JN, Seeger M, Relkin NR, Liao F, Checler F, Buxbaum JD, Chait BT, Thinakaran G, Sisodia SS, Wang R, Greengard P, Gandy S. (1998). Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med 4:447-451. (Pubitemid 28212761)
34. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X. (1997). Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275: 1129-1132. (Pubitemid 27097312)
35. Zhu X, Raina AK, Lee HG, Casadesus G, Smith MA, Perry G. (2004). Oxidative stress signalling in Alzheimer's disease. Brain Res 1000:32-39. (Pubitemid 38446487)